SK Bioscience suspends production of COVID-19 vaccine

SK Bioscience obtained item approval on June 29 and supplied vaccines on September under a pre-purchase contract...

South Korea: SK Bioscience to develop COVID-flu combo vaccine

Seoul [South Korea], February 22 (ANI/Global Economic): As 'flurona,' which means having both COVID-19 and influenza...

SK Bioscience to develop COVID-19 Omicron-specific vaccine

Seoul [South Korea], February 9 (ANI/Global Economic): As the Omicron COVID-19 variant, which is now the most...

SK Bioscience to purchase 5 million doses of additional...

Seoul [South Korea], January 3 (ANI/Global Economic): SK Bioscience signed a contract to pre-purchase up to 5...

Korean bio 'Big 3' Samsung, Celltrion, SK to expand their...

Seoul [South Korea], December 29 (ANI/Global Economic): As SK Bioscience announced its plan to open a new R&PD...

SK Bioscience to invest 150 billion won in vaccine factory...

Seoul [South Korea], June 22 (ANI/Global Economic): SK Bioscience has begun work to become a hub for global vaccine...

Mirae Asset No. 1 in civil complaints among securities...

Seoul [South Korea], May 11 (ANI/Global Economic): This year, Mirae Asset Securities showed the largest number of...